158 related articles for article (PubMed ID: 12172583)
21. Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypes.
Singh K; Paquette C; Kalife ET; Wang Y; Mangray S; Quddus MR; Steinhoff MM
Hum Pathol; 2018 Aug; 78():163-170. PubMed ID: 29753007
[TBL] [Abstract][Full Text] [Related]
22. Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas.
Frolik D; Caduff R; Varga Z
Histopathology; 2001 Nov; 39(5):503-13. PubMed ID: 11737309
[TBL] [Abstract][Full Text] [Related]
23. Invasive Lobular Carcinoma Mimicking Papillary Carcinoma: A Report of Three Cases.
Rakha EA; Abbas A; Sheeran R
Pathobiology; 2016; 83(5):221-7. PubMed ID: 27116593
[TBL] [Abstract][Full Text] [Related]
24. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases.
Sneige N; Wang J; Baker BA; Krishnamurthy S; Middleton LP
Mod Pathol; 2002 Oct; 15(10):1044-50. PubMed ID: 12379750
[TBL] [Abstract][Full Text] [Related]
25. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
26. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
Sullivan PS; Apple SK
Breast J; 2009; 15(2):146-54. PubMed ID: 19292800
[TBL] [Abstract][Full Text] [Related]
27. Lobular carcinoma in situ and infiltrating ductal carcinoma: frequent presence of DCIS as a precursor lesion.
Maluf H; Koerner F
Int J Surg Pathol; 2001 Apr; 9(2):127-31. PubMed ID: 11484500
[TBL] [Abstract][Full Text] [Related]
28. Cadherin-catenin complex dissociation in lobular neoplasia of the breast.
Morrogh M; Andrade VP; Giri D; Sakr RA; Paik W; Qin LX; Arroyo CD; Brogi E; Morrow M; King TA
Breast Cancer Res Treat; 2012 Apr; 132(2):641-52. PubMed ID: 22080244
[TBL] [Abstract][Full Text] [Related]
29. [Breast carcinoma, apocrine variety].
Guidugli Neto J; Kogos W
Rev Paul Med; 1990; 108(5):239-40. PubMed ID: 1966399
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic and biomarker analysis of invasive pleomorphic lobular carcinoma as compared with invasive classic lobular carcinoma: an experience in our institution and review of the literature.
Jacobs M; Fan F; Tawfik O
Ann Diagn Pathol; 2012 Jun; 16(3):185-9. PubMed ID: 22197540
[TBL] [Abstract][Full Text] [Related]
31. Histiocytoid breast carcinoma: an enigmatic lobular entity.
Tan PH; Harada O; Thike AA; Tse GM
J Clin Pathol; 2011 Aug; 64(8):654-9. PubMed ID: 21398688
[TBL] [Abstract][Full Text] [Related]
32. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma.
Wahed A; Connelly J; Reese T
Ann Diagn Pathol; 2002 Dec; 6(6):349-51. PubMed ID: 12478484
[TBL] [Abstract][Full Text] [Related]
33. Pleomorphic lobular carcinoma in pleural fluid: diagnostic pitfall for atypical mesothelial cells.
Monaco SE; Dabbs DJ; Kanbour-Shakir A
Diagn Cytopathol; 2008 Sep; 36(9):657-61. PubMed ID: 18677762
[TBL] [Abstract][Full Text] [Related]
34. The evaluation of high risk and pre-invasive breast lesions and the decision process for follow up and surgical intervention.
Simmons RM; Osborne MP
Surg Oncol; 1999 Aug; 8(2):55-65. PubMed ID: 10732957
[TBL] [Abstract][Full Text] [Related]
35. Pleomorphic lobular carcinoma of the breast: molecular pathology and clinical impact.
Vargas AC; Lakhani SR; Simpson PT
Future Oncol; 2009 Mar; 5(2):233-43. PubMed ID: 19284381
[TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
37. Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.
Merrill AL; Coopey SB; Tang R; McEvoy MP; Specht MC; Hughes KS; Gadd MA; Smith BL
Ann Surg Oncol; 2016 Mar; 23(3):729-34. PubMed ID: 26467458
[TBL] [Abstract][Full Text] [Related]
38. The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type.
Weigelt B; Geyer FC; Natrajan R; Lopez-Garcia MA; Ahmad AS; Savage K; Kreike B; Reis-Filho JS
J Pathol; 2010 Jan; 220(1):45-57. PubMed ID: 19877120
[TBL] [Abstract][Full Text] [Related]
39. Pleomorphic lobular carcinoma of the breast: a comparison of cytopathological features with other lobular carcinoma variants.
Ohashi R; Matsubara M; Watarai Y; Yanagihara K; Yamashita K; Tsuchiya SI; Takei H; Naito Z
Cytopathology; 2017 Apr; 28(2):122-130. PubMed ID: 27489086
[TBL] [Abstract][Full Text] [Related]
40. Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy.
Houssami N; Ambrogetti D; Marinovich ML; Bianchi S; Macaskill P; Vezzosi V; Mamounas EP; Ciatto S
Ann Surg Oncol; 2011 May; 18(5):1364-71. PubMed ID: 21107741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
